Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.7K Buy
20,815
+380
+2% +$686 ﹤0.01% 455
2025
Q4
$37.8K Hold
20,435
﹤0.01% 429
2025
Q3
$32.7K Sell
20,435
-2,800
-12% -$5.12K ﹤0.01% 435
2025
Q2
$40.4K Buy
23,235
+1,035
+5% +$1.73K ﹤0.01% 404
2025
Q1
$53.3K Buy
22,200
+1,720
+8% +$5.63K 0.01% 369
2024
Q4
$72.5K Hold
20,480
0.01% 351
2024
Q3
$86.6K Hold
20,480
0.01% 346
2024
Q2
$76.8K Hold
20,480
0.01% 338
2024
Q1
$111K Sell
20,480
-6,135
-23% -$35.3K 0.01% 299
2023
Q4
$164K Hold
26,615
0.02% 263
2023
Q3
$138K Buy
+26,615
New +$142K 0.02% 238

Other funds holding OABI

BFSG LLC's OABI Position: Q1 2026 in Review

BFSG LLC increased its OmniAb (OABI) stake by 1.9% in Q1 2026, buying an estimated $686 and bringing the position to 20,815 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

BFSG LLC first reported a position in OABI in Q3 2023 and has held it in 11 quarters since. The position peaked at $164K in Q4 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • BFSG LLC held 20,815 shares of OmniAb worth $32.7K as of Q1 2026.
  • BFSG LLC bought 380 OmniAb shares in Q1 2026, an estimated $686.
  • OmniAb made up ﹤0.01% of BFSG LLC's portfolio in Q1 2026, its #455 holding.
  • BFSG LLC first reported a position in OmniAb in Q3 2023 and has held it in 11 quarters since.
  • BFSG LLC's OmniAb position peaked at $164K in Q4 2023.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.